Crinetics Pharmaceuticals, Inc. (CRNX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -124.7M | -92.9M | -110.72M | -85.85M | -88.45M | -64.67M | -60.8M | -47.64M | -52.86M | -38.52M | -41.34M | -45.73M | -40.72M | -35.21M | -38.48M | -27.98M | -13.54M | -22.9M | -25.67M | -19.95M |
| Operating CF Margin % | -1161.76% | -1507.89% | -77425.17% | -8326.96% | -24501.94% | - | - | -11940.85% | -8258.75% | - | -11947.69% | -4629.05% | -1519.9% | -4965.73% | -8401.53% | -6372.67% | -432.55% | -2124.21% | - | - |
| Operating CF Growth % | -40.98% | -43.65% | -82.11% | -80.19% | -67.35% | -67.92% | -47.07% | -4.17% | -29.81% | -9.4% | -7.43% | -63.48% | -200.66% | -53.75% | -49.88% | -40.24% | 32.51% | -43.68% | -42.6% | -25.82% |
| Net Income | -127.84M | -122.81M | -130.09M | -115.64M | -96.77M | -80.59M | -76.83M | -74.06M | -66.93M | -60.1M | -57.46M | -50.98M | -45.99M | -44.99M | -41.92M | -42.38M | -34.63M | -30.79M | -27.85M | -26.09M |
| Depreciation & Amortization | 1.16M | 994K | 1.01M | 959K | 925K | 788K | 770K | 753K | 474K | 262K | 273K | 280K | 398K | 388K | 248K | 315K | 335K | 235K | 233K | 230K |
| Stock-Based Compensation | 29.68M | 21.72M | 22.7M | 26.12M | 20.48M | 18.84M | 18.15M | 18.94M | 13.45M | 11.62M | 11.05M | 10.18M | 0 | 0 | 7.43M | 0 | 0 | 5.16M | 4.55M | 4.23M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.21M | -905K | 0 | 0 | 0 | 0 | 0 | 186K | 0 | 0 |
| Other Non-Cash Items | -1.5M | -2.07M | -2.85M | -3.9M | -3.54M | -3.4M | -2.76M | -2.66M | -2.55M | 1.4M | 7.15M | 118K | 5.57M | 7.03M | -29K | 7.29M | 7.09M | -996K | 161K | 169K |
| Working Capital Changes | -26.2M | 9.27M | -1.5M | 6.6M | -9.54M | -308K | -125K | 9.38M | 2.69M | 8.3M | 4.85M | -4.42M | -687K | 2.37M | -4.21M | 6.79M | 13.66M | 3.31M | -2.77M | 1.51M |
| Change in Receivables | -5.09M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -909K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -12.06M | 11.18M | 6.65M | 12.52M | -1.36M | 0 | 0 | 0 | 1.31M | 4.19M | 4.38M | 7.42M | -1.34M | 4.08M | 0 | 6.71M | 1.53M | 3.9M | 494K | 2.17M |
| Cash from Investing | -252.36M | 57.11M | 164.81M | 37.95M | -85.96M | -542.09M | 20.6M | -53.64M | 309K | -87.31M | -193.3M | 31.44M | 48.76M | 36.85M | 6.82M | -174.27M | -43.38M | -101.8M | -7.03M | 19.84M |
| Capital Expenditures | -820K | -458K | -863K | -3.2M | -1.24M | -1.03M | -528K | -955K | -1.33M | -935K | -3.5M | -237K | -16K | -274K | -682K | -613K | -87K | -18K | -140K | -162K |
| CapEx % of Revenue | 7.64% | 7.43% | 603.5% | 310.57% | 343.21% | - | - | 239.35% | 208.12% | - | 1011.56% | 23.99% | 0.6% | 38.65% | 148.91% | 139.64% | 2.78% | 1.67% | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 189.8M | -31.67M | 0 | 0 | 0 | 0 | 0 | 101.8M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 2.22M | -1.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -189.8M | 31.67M | 0 | 0 | 0 | 0 | 0 | -101.8M | 0 | 0 |
| Cash from Financing | 389.88M | 26.04M | 3.08M | 7.05M | 4.44M | 554.04M | 55.3M | 7.52M | 393.57M | 37.92M | 337.88M | 12.66M | 484K | 115K | 1.08M | 118.99M | 1.78M | 163.86M | 15.46M | 73.3M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 389.88M | 26.04M | 3.08M | 7.05M | 4.44M | 544.5M | 32.19M | 10.14M | 383.21M | 28.75M | 328.96M | 11.31M | 484K | 115K | -13K | 118.99M | 1.78M | 162.01M | 14.98M | 72.56M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 9.54M | 23.11M | -2.62M | 10.36M | 9.17M | 8.92M | 1.35M | 0 | 0 | 1.09M | 0 | 0 | 1.85M | 487K | 745K |
| Net Change in Cash | 12.8M | -9.87M | 57.17M | -40.84M | -169.98M | -52.72M | 15.11M | -93.76M | 341.03M | -87.9M | 103.24M | -1.64M | 8.52M | 1.76M | -30.58M | -83.25M | -55.15M | 39.16M | -17.23M | 73.19M |
| Free Cash Flow | -125.52M | -93.36M | -111.58M | -89.05M | -89.69M | -65.7M | -61.32M | -48.6M | -54.19M | -39.45M | -44.84M | -45.97M | -40.73M | -35.48M | -39.16M | -28.59M | -13.63M | -22.92M | -25.81M | -20.11M |
| FCF Margin % | -1169.4% | -1515.32% | -78028.67% | -8637.54% | -24845.15% | - | - | -12180.2% | -8466.88% | - | -12959.25% | -4653.04% | -1520.49% | -5004.37% | -8550.44% | -6512.3% | -435.32% | -2125.88% | - | - |
| FCF Growth % | -39.95% | -42.09% | -81.95% | -83.24% | -65.52% | -66.55% | -36.76% | -5.71% | -33.03% | -11.19% | -14.5% | -60.8% | -198.86% | -54.82% | -51.71% | -42.16% | 32.47% | -43.64% | -42.61% | -26.75% |
| FCF per Share | -1.21 | -0.99 | -1.18 | -0.95 | -0.96 | -0.72 | -0.77 | -0.62 | -0.75 | -0.59 | -0.79 | -0.85 | -0.76 | -0.66 | -0.73 | -0.54 | -0.29 | -0.51 | -0.67 | -0.54 |
| FCF Conversion (FCF/Net Income) | 0.98x | 0.76x | 0.85x | 0.74x | 0.91x | 0.80x | 0.79x | 0.64x | 0.79x | 0.64x | 0.72x | 0.90x | 0.89x | 0.78x | 0.92x | 0.66x | 0.39x | 0.74x | 0.92x | 0.76x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |